Red Cell Partners
Red Cell Partners is a privately held venture studio founded in 2020 and based in McLean, Virginia, that creates and scales technology companies in healthcare, cyber, and national security, with 15 companies created, 9 launched, and $497 million raised across the firm and portfolio as of June 2026.
- Company typePrivate
- Founded2020
- HeadquartersWashington, United States
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Red Cell Partners does
Red Cell Partners is a privately held venture studio founded in 2020 by Grant Verstandig and headquartered in McLean, Virginia, with additional offices in Washington D.C. and Los Angeles. The firm creates, incubates, and scales technology companies across three practice areas — healthcare, cyber, and national security — using a deliberate four-stage process (Discovery, Startup, NewCo, Growth) supported by a six-department internal platform covering HR, legal, finance, product engineering, brand marketing, and operations. As of June 2026, Red Cell has created 15 companies, launched 9 publicly, employs 75 full-time staff, and has helped its incubations reach external capital at an average of 16 months from initial funding, with $497 million raised cumulatively across the firm and portfolio.
The portfolio spans AI-native and deep-tech platforms: Trase (multi-agent AI operating system for regulated industries, with anchor deployment at Duke Health and the U.S. Navy), Claros (chip-to-grid power management for AI data centers, partnered with Samsung Foundry), Andesite (AI-powered bionic SOC for cybersecurity, $38.25M raised), DEFCON AI (AI-driven defense logistics simulation), Zephyr AI (precision medicine with the AIM-Bx and Zephyr Nexus platforms), Crux (employer benefits platform for GLP-1 medications partnered with Ochsner), TARA Mind (mental health therapies including ketamine-assisted treatment), Hunted Labs (open-source software threat hunting), Savoy Life (virtual care for senior living), DeployX (advanced RF communications for military), LightBox (healthcare revenue cycle automation), Sparrow Healthcare (community-based care delivery), and minority stakes in Valinor Enterprises (defense-tech holding company, $85M+ raised) and Evoke Security (AI agent cybersecurity).
Red Cell's revenue model is equity-based rather than transactional: the firm generates returns through ownership stakes in its incubations rather than direct product sales, with operating expenses funded by founder capital, LP commitments, and management economics on capital deployed. Customer end-markets are accessed through portfolio companies across three verticals — healthcare organizations (hospitals, health systems, payers), enterprise and government cybersecurity buyers, and U.S. Department of Defense and intelligence community agencies. The firm's competitive positioning rests on its leadership bench (former NSA Deputy Director George Barnes, former Secretary of Defense Mark T. Esper, former Assistant Secretary of Defense Veronica Daigle, former Navy SEAL David Silverman) and repeat co-investment relationships with tier-1 venture firms including General Catalyst, Bessemer Venture Partners, and ARCH Venture Partners.
Red Cell Partners firmographics
Firmographics- Name
- Red Cell Partners
- Legal name
- Red Cell Partners, LLC
- Website
- https://redcellpartners.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Red Cell Partners is a privately held venture studio founded in 2020 and based in McLean, Virginia, that creates and scales technology companies in healthcare, cyber, and national security, with 15 companies created, 9 launched, and $497 million raised across the firm and portfolio as of June 2026.
- Ownership category
- akta.pro rank
Red Cell Partners industry classification
Industry- Product category
- Venture Studio / Technology Incubation
- NAICS
- Miscellaneous Intermediation (523910)
- SIC
- Services-Management Consulting Services (8742)
- akta.pro primary industry
- Corporate Venture Studios & Incubators (Build/launch ventures) (FSANAHAC)
- akta.pro secondary industry
- Corporate Innovation & Technology Scouting Units (with investment mandate) (FSANAHAI)
Keywords
Where Red Cell Partners is headquartered
LocationHeadquarters
- HQ city
- Washington
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Red Cell Partners business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Equity holdings in portfolio companies: Red Cell generates returns through equity ownership in its incubated and invested companies. The firm has raised $497M across the firm and its incubations, with multiple portfolio companies raising significant external funding rounds.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Red Cell Partners product offering
Product offeringCore offering
Red Cell Partners is a venture studio that creates, incubates, and scales technology companies in the healthcare, cyber, and national security sectors. The firm identifies market opportunities, recruits founders, provides initial capital, and supplies a cross-functional platform team (HR, legal, finance, product & engineering, brand marketing, operations) to move incubations from idea through independent external funding. Returns are generated through equity ownership in the incubated companies.
Product overview
Red Cell Partners is a venture studio that creates and scales technology companies in healthcare, cyber, and national security sectors. The portfolio comprises multiple distinct platforms: Trase provides a multi-agent AI operating system for healthcare, defense, and energy workflows; Claros offers a chip-to-grid power management platform for data centers; Andesite delivers an AI-powered bionic SOC for cybersecurity; DEFCON AI provides logistics simulation with AI-driven agents; Zephyr AI develops precision medicine tools for drug development; TARA Mind offers mental health therapy benefit programs; Crux operates an employer benefits platform for medications; Hunted Labs provides AI/ML threat hunting; Savoy Life delivers virtual healthcare for senior living; and DeployX pioneers advanced radio-frequency communications. These products range from AI agent platforms and security tools to healthcare benefits and power management solutions, addressing critical infrastructure needs across regulated industries.
Differentiator
Problem solved
Functional benefit
Products and services
- Trase AI operating system and multi-agent platform for regulated industries (healthcare, defense, energy) that automates complex administrative workflows through autonomous AI agents that coordinate like white blood cells. Replaces manual, repetitive processes with secure, audit-ready agents and has demonstrated 7.1x faster fax triage at Duke Health.
- Claros Chip-to-grid power management platform for data centers that innovates at the intersection of power and compute. Features integrated voltage regulators (IVR) and DC-native Power Gateway to reduce energy waste from AI workloads, in strategic manufacturing collaboration with Samsung Foundry.
- Andesite Bionic SOC AI-powered bionic Security Operations Center (SOC) platform enabling collaboration between human analysts and AI. Connects siloed data across security ecosystems to accelerate threat detection, investigation, and response, and helps teams shift from reactive alert triage to proactive threat hunting.
- Crux No-fee employer benefits platform partnering with pharmaceutical companies to expand affordable access to quality-of-life medications, starting with GLP-1s for obesity management.
- DEFCON AI Decision-support and logistics simulation platform using AI-driven intelligent agents for military logistics planning. The Artiv platform merges next-generation modeling and simulation with intelligent agents to deliver operational wargaming analysis in minutes for contested mobility scenarios.
- Zephyr AI Precision medicine company developing AI-enabled tools (AIM-Bx for drug response prediction and Zephyr Nexus for real-world insights) operating on large-scale real-world clinico-genomic data to accelerate drug development and improve outcomes in oncology and cardiometabolic disease.
- TARA Mind Health-tech company building innovative benefit programs for mental health therapies through a national provider network and collaborative care platform, offering ketamine-assisted therapy access for treatment-resistant depression.
- Hunted Labs AI/ML-powered threat hunting and unified threat management platform for the software development lifecycle, providing visibility across open source software ecosystems to identify and remediate malicious threats and reduce remediation time.
- Savoy Life Virtual healthcare solution platform bringing health and compliance support services to the long-term care industry, helping adult family homes and assisted living communities close healthcare gaps and improve quality of life for seniors.
- DeployX Advanced communications company pioneering integrated radio-frequency technologies for mission-critical operations, delivering secure, reliable long-range communications for military connectivity with critical assets and distributed forces.
- Valinor Enterprises Operational holding company for defense and government technology using a hub-and-spoke model, with multiple Product Companies covering military construction, munition lifecycle management, maritime support, mobile medical systems, smart optics, and unmanned aircraft systems. Has partnerships with Anduril and Palantir.
- Evoke Security Cybersecurity platform providing visibility and control over AI agents accessing sensitive corporate data and systems, addressing enterprise security gaps for autonomous AI agents in production environments.
- LightBox AI-powered revenue cycle intelligence and automation platform for healthcare providers.
- Sparrow Healthcare Trusted community-based healthcare delivery platform providing care that starts in local communities.
Quantifiable outcome
- 15 companies created with 9 publicly launched as of June 2026
- +2 more outcomes
Companies that use Red Cell Partners
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles4 records
Red Cell Partners technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability9 records
Feature2 records
Red Cell Partners partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core and minor.
- Samsung FoundrycoreStrategic manufacturing collaboration with Samsung Foundry to produce integrated voltage regulators for AI data centers, supporting Claros' chip-to-grid power management solutions.
- Ochsner Connected HealthcorePartnership with Crux to launch obesity management medicine benefits platform for employers nationwide.
- Google CloudcoreTrase's AI agents are available on Google Cloud Marketplace, enabling organizations to deploy Trase's multi-agent systems for enterprise productivity.
- Duke HealthcoreDuke Health partnered with Trase to develop AI healthcare tools, deploying autonomous AI agents for healthcare workflows including fax triage and administrative process automation. Initial results showed 7.1x faster processing and significant time savings.
- Aster InsightscoreZephyr AI acquired Aster Insights (formerly M2Gen) to expand its clinicogenomic data resources and accelerate precision medicine algorithms.
- UMass Chan Medical SchoolcoreStrategic collaboration to advance AI in healthcare, supporting Red Cell's healthcare practice and portfolio companies.
- AndurilminorValinor has partnered with Anduril to build and acquire critical defense technology solutions.
- PalantirminorValinor has partnered with Palantir as part of its defense tech ecosystem strategy.
Scale indicators12 records
Recent moves7 records
Expansion highlights6 records
Red Cell Partners competitors and assessment
Company assessmentDirect peers
- In-Q-Tel: The CIA's strategic not-for-profit investor that identifies, funds, and accelerates technology companies for the U.S. intelligence community. Most directly comparable to Red Cell's cyber and national security practice, including the same mission-aligned approach and government customer focus.
- General Catalyst: Flagship co-investor across multiple Red Cell portfolio companies (Andesite, Claros, Valinor). A late-stage VC increasingly building company-creation capabilities (e.g., GC Institute) that overlap with Red Cell's studio model, especially in healthcare and national security.
- ARCH Venture Partners: Led Trase's $107M seed round in 2026 and is a long-tenured deep-tech/healthcare investor that also actively creates and spins out companies from academic research. Comparable to Red Cell in its willingness to incubate breakthrough science in regulated industries.
- Bessemer Venture Partners: Lead investor in DEFCON AI's seed and a co-investor across Red Cell's portfolio. A multi-stage firm with deep defense-tech and healthcare exposure that increasingly partners with — and sometimes competes with — studio-style origination models.
- SRI International: A nonprofit research institute that creates and spins out technology companies in healthcare, cyber, and national security. Conceptually very close to Red Cell's studio model, combining R&D with company creation, though structured as a non-profit.
- Lux Capital: A deep-tech investor that actively incubates companies at the intersection of science, technology, and government/dual-use applications. Comparable in its willingness to back hard-tech and national-security bets and in building concentrated founder networks.
- Allen & Company: A closely held private investment bank with a founder-led, relationship-driven model similar to Red Cell's approach. Comparable in scale, discretion, and focus on long-duration capital partnerships rather than traditional fund structures.
Broad incumbents
- Anduril Industries: A leading defense-tech prime that Valinor has explicitly partnered with. Operates broadly across defense and national security with overlapping interest in autonomous systems, comms, and counter-drone — the same verticals where Red Cell's DeployX and DEFCON AI operate.
- Palantir Technologies: A defense/cyber and data analytics incumbent that Valinor partners with. Comparable to Red Cell's defense and cyber practices in its government buyer relationships and AI-driven mission software, though it is a much larger, public company.
- Booz Allen Hamilton: A large defense and intelligence consulting firm with deep government relationships and AI practice that overlaps with Red Cell's national security and cyber practices. Serves the same federal buyer base though at significantly greater scale and breadth.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Red Cell Partners social profiles
Digital presenceRed Cell Partners financial estimates
Financial estimateRevenue estimate
Valuation estimate
Red Cell Partners leadership team
Management profileNumber of profiles
Profiles17 records
Red Cell Partners subsidiaries and ownership
Company hierarchySubsidiaries15 records
Red Cell Partners funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Red Cell Partners M&A and investment
M&A and investmentM&A
Investments20 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Red Cell Partners
What does Red Cell Partners do?
Red Cell Partners is a venture studio that creates, incubates, and scales technology companies in the healthcare, cyber, and national security sectors. The firm identifies market opportunities, recruits founders, provides initial capital, and supplies a cross-functional platform team (HR, legal, finance, product & engineering, brand marketing, operations) to move incubations from idea through independent external funding. Returns are generated through equity ownership in the incubated companies.
Is Red Cell Partners a public or private company?
Red Cell Partners is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Red Cell Partners founded?
Red Cell Partners was founded in 2020. It employs 51 to 100 people.
Where is Red Cell Partners based?
Red Cell Partners is headquartered in Washington, United States, in the North America region.
How does Red Cell Partners make money?
One revenue line is on record: equity holdings in portfolio companies.
Who are Red Cell Partners's main competitors?
Direct peers on record are In-Q-Tel, General Catalyst, ARCH Venture Partners, Bessemer Venture Partners, SRI International, Lux Capital and Allen & Company. Broad incumbents are Anduril Industries, Palantir Technologies and Booz Allen Hamilton.
Does Red Cell Partners have an API?
No public API is recorded for Red Cell Partners.
What industry is Red Cell Partners in?
Red Cell Partners's product category is Venture Studio / Technology Incubation. Its primary akta.pro industry code is FSANAHAC, Corporate Venture Studios & Incubators (Build/launch ventures), with a secondary code of FSANAHAI, Corporate Innovation & Technology Scouting Units (with investment mandate). Its NAICS code is 523910 and its SIC code is 8742.